 |
Atalanta Therapeutics
Alicia Secor, CEO
USA | Funding: $207M (+)
Website: https://www.atalantatx.com/
Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases by utilizing our proprietary RNA interference platform.
Website: https://www.atalantatx.com/
Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases by utilizing our proprietary RNA interference platform.
